May 22, 2019

Winnipeg
14° C, Light rain showers

Full Forecast

Advertisement

Advertise With Us

Donation opens doors for Alzheimer's study subjects

Zahra Moussavi is analyzing the use of repetitive transcranial magnetic stimulation on subjects with early-to-moderate-stage dementia and Alzheimer's. (Mike Deal / Winnipeg Free Press)</p>

Zahra Moussavi is analyzing the use of repetitive transcranial magnetic stimulation on subjects with early-to-moderate-stage dementia and Alzheimer's. (Mike Deal / Winnipeg Free Press)

A Winnipeg researcher who is studying a potential treatment for Alzheimer’s disease is looking for more participants for her program —and just got the funding to help more people access it.

Zahra Moussavi, a biomedical engineer and University of Manitoba professor, is analyzing the use of repetitive transcranial magnetic stimulation (rTMS) on subjects with early- to moderate-stage dementia and Alzheimer’s, which affects an estimated 22,500 Manitobans. Dementia has no known cure and is nearing pandemic levels worldwide, as the baby boom generation ages.

For roughly 30 minutes a day, five days a week, for four weeks, a magnetic coil is held over the patient’s head, sending 20 high-frequency pulses per second to the brain.

“When we give them at a high frequency, it excites the neurons,” Moussavi said. “It’s helping neurons that have become inactive.

Get the full story.
No credit card required. Cancel anytime.

Join free for 30 days

After that, pay as little as $0.99 per month for the best local news coverage in Manitoba.

 

Already a subscriber?

Log in

Join free for 30 days

 

Already a subscriber?

Log in

Subscribers Log in below to continue reading,
not a subscriber? Create an account to start a 30 day free trial.

Log in Create your account

Your free trial has come to an end.

We hope you have enjoyed your trial! To continue reading, we recommend our Read Now Pay Later membership. Simply add a form of payment and pay only 27¢ per article.

For unlimited access to the best local, national, and international news and much more, try an All Access Digital subscription:

Thank you for supporting the journalism that our community needs!

Your free trial has come to an end.

We hope you have enjoyed your trial! To continue reading, we recommend our Read Now Pay Later membership. Simply add a form of payment and pay only 27¢ per article.

For unlimited access to the best local, national, and international news and much more, try an All Access Digital subscription:

Thank you for supporting the journalism that our community needs!

We hope you have enjoyed your free trial!

To continue reading, select a plan below:

All Access Digital

Introductory pricing*

99¢

per month

  • Unlimited online reading and commenting
  • Daily newspaper replica e-Edition
  • News Break - our award-winning iOS app
  • Exclusive perks & discounts
Continue

Read Now Pay Later

Pay

27¢

per article

  • Commitment-free
  • Cancel anytime
  • Only pay for what you read
  • Refunds available
Continue

*Introductory pricing schedule for 12 month: $0.99/month plus tax for first 3 months, $5.99/month for months 4 - 6, $10.99/month for months 7 - 9, $13.99/month for months 10 - 12. Standard All Access Digital rate of $16.99/month begins after first year.

We hope you have enjoyed your free trial!

To continue reading, select a plan below:

Read Now Pay Later

Pay

27¢

per article

  • Commitment-free
  • Cancel anytime
  • Only pay for what you read
  • Refunds available
Continue

All Access Digital

Introductory pricing*

99¢

per month

  • Unlimited online reading and commenting
  • Daily newspaper replica e-Edition
  • News Break - our award-winning iOS app
  • Exclusive perks & discounts
Continue

Mon to Sat Delivery

Pay

$34.36

per month

  • Includes all benefits of All Access Digital
  • 6-day delivery of our award-winning newspaper
Continue

*Introductory pricing schedule for 12 month: $0.99/month plus tax for first 3 months, $5.99/month for months 4 - 6, $10.99/month for months 7 - 9, $13.99/month for months 10 - 12. Standard All Access Digital rate of $16.99/month begins after first year.

We hope you have enjoyed your free trial!

To continue reading, select a plan below:

All Access Digital

Introductory pricing*

99¢

per month

  • Unlimited online reading and commenting
  • Daily newspaper replica e-Edition
  • News Break - our award-winning iOS app
  • Exclusive perks & discounts
Continue

Read Now Pay Later

Pay

27¢

per article

  • Commitment-free
  • Cancel anytime
  • Only pay for what you read
  • Refunds available
Continue

*Introductory pricing schedule for 12 month: $0.99/month plus tax for first 3 months, $5.99/month for months 4 - 6, $10.99/month for months 7 - 9, $13.99/month for months 10 - 12. Standard All Access Digital rate of $16.99/month begins after first year.

We hope you have enjoyed your free trial!

To continue reading, select a plan below:

Read Now Pay Later

Pay

27¢

per article

  • Commitment-free
  • Cancel anytime
  • Only pay for what you read
  • Refunds available
Continue

All Access Digital

Introductory pricing*

99¢

per month

  • Unlimited online reading and commenting
  • Daily newspaper replica e-Edition
  • News Break - our award-winning iOS app
  • Exclusive perks & discounts
Continue

*Introductory pricing schedule for 12 month: $0.99/month plus tax for first 3 months, $5.99/month for months 4 - 6, $10.99/month for months 7 - 9, $13.99/month for months 10 - 12. Standard All Access Digital rate of $16.99/month begins after first year.

A Winnipeg researcher who is studying a potential treatment for Alzheimer’s disease is looking for more participants for her program —and just got the funding to help more people access it.

Zahra Moussavi, a biomedical engineer and University of Manitoba professor, is analyzing the use of repetitive transcranial magnetic stimulation (rTMS) on subjects with early- to moderate-stage dementia and Alzheimer’s, which affects an estimated 22,500 Manitobans. Dementia has no known cure and is nearing pandemic levels worldwide, as the baby boom generation ages.

For roughly 30 minutes a day, five days a week, for four weeks, a magnetic coil is held over the patient’s head, sending 20 high-frequency pulses per second to the brain.

"When we give them at a high frequency, it excites the neurons," Moussavi said. "It’s helping neurons that have become inactive.

"We don’t expect the treatment to make a miracle, but we have seen people who are responsive to rTMS," said the researcher seeking to learn if the process — which has been used for decades to treat a number of neurological and psychiatric conditions — can reduce the effects of Alzheimer’s and fight the progression of the disease.

To do that, she needs at least 100 study participants. However, for people with dementia, getting around isn’t easy.

"Someone has to bring the patient every day," said Moussavi, who received $1.8 million from the Weston Brain Institute in 2016 for the study, which she runs at three sites: in Winnipeg at Riverview Health Centre, Montreal and Melbourne, Australia.

Globally, it’s the largest study for the potential treatment of Alzheimer’s using the pulsating magnetic coil.

"Some patients have no one to drive them," said Moussavi, who recently received a four-year, $400,000 donation to help with transportation costs of study participants in Manitoba.

"This donation allows people to come," she said. So far, there have been participants from Winnipeg, Gimli, and as far away as a three-hour drive. "Some had family members here who they stayed with."

With the recent donation, Moussavi can pay for participants to take a cab to and from Riverview, and open up the program to out-of-towners. "I can help them with $2,000 for the family to rent accommodations in Winnipeg for the duration of the treatment."

So far, Moussavi, who is also studying the effect of brain exercises on dementia patients, has had 36 participants in the rTMS study."Not everybody is responsive to rTMS," she said.

The Alzheimer Society of Manitoba said it is interested in the program’s results. By using a control group and a treatment group, Moussavi’s study should highlight its effectiveness, said Norma Kirkby, the society’s program co-ordinator.

"It will be able to give good evidence on its outcomes," Kirkby said. Those who are in the control group and not receiving rTMS are eligible to undergo treatments after completing the series.

The society has had feedback from some study subjects, saying the treatment was beneficial, and from others who said it made no difference, Kirkby said.

In the end, the hope is "everyone will know what its potential is."

carol.sanders@freepress.mb.ca

Carol Sanders

Carol Sanders
Reporter

Carol Sanders’ reporting on newcomers to Canada has made international headlines, earned national recognition but most importantly it’s shared the local stories of the growing diversity of people calling Manitoba home.

Read full biography

Advertisement

Advertise With Us

History

Updated on Saturday, January 5, 2019 at 8:45 AM CST: Final

You can comment on most stories on The Winnipeg Free Press website. You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or digital subscriber to join the conversation and give your feedback.

Have Your Say

Have Your Say

Comments are open to The Winnipeg Free Press print or digital subscribers only. why?

Have Your Say

Comments are open to The Winnipeg Free Press Subscribers only. why?

By submitting your comment, you agree to abide by our Community Standards and Moderation Policy. These guidelines were revised effective February 27, 2019. Have a question about our comment forum? Check our frequently asked questions.

Advertisement

Advertise With Us